{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:34:57Z","timestamp":1790289297808,"version":"4.1.0"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01940","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T09:14:06Z","timestamp":1565774046000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":89,"title":["The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer"],"prefix":"10.3389","volume":"10","author":[{"given":"Adviti","family":"Naik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arta Monir","family":"Monjazeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Decock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1158\/1078-0432.CCR-10-1533","article-title":"Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study","volume":"16","author":"O'Brien","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1309\/AJCPQN8GZ8SILKGN","article-title":"Triple-negative breast carcinoma: current and emerging concepts","volume":"141","author":"Schmadeka","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40425-018-0397-8","article-title":"The age of enlightenment in melanoma immunotherapy","volume":"6","author":"Albertini","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrclinonc.2017.176","article-title":"Acute lymphoblastic leukaemia in 2017: immunotherapy for ALL takes the world by storm","volume":"15","author":"Teachey","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e000150","DOI":"10.1136\/esmoopen-2016-000150","article-title":"Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer","volume":"2","author":"Kitano","year":"2017","journal-title":"ESMO Open"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1200\/JCO.2015.64.8931","article-title":"Pembrolizumab in patients with advanced triple-negative breast cancer: phase Ib KEYNOTE-012 study","volume":"34","author":"Nanda","year":"2016","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-018-0126-6","article-title":"Checkpoint blockade in the treatment of breast cancer: current status and future directions","volume":"119","author":"Wein","year":"2018","journal-title":"Br J Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.canlet.2018.10.042","article-title":"Immunological therapy: a novel thriving area for triple-negative breast cancer treatment","volume":"442","author":"Wang","year":"2019","journal-title":"Cancer Lett"},{"key":"B13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"k793","DOI":"10.1136\/bmj.k793","article-title":"Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis","volume":"360","author":"Baxi","year":"2018","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1136\/annrheumdis-2018-eular.6275","article-title":"SAT0715 risk factors of immune-related adverse events in patients treated with anti-pd-1 antibody pembrolizumab","volume":"77","author":"Eun","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fendo.2013.00071","article-title":"Adipokines mediate inflammation and insulin resistance","volume":"4","author":"Kwon","year":"2013","journal-title":"Front Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrc3967","article-title":"Adiposity and cancer risk: new mechanistic insights from epidemiology","volume":"15","author":"Renehan","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","article-title":"Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study","volume":"335","author":"Reeves","year":"2007","journal-title":"BMJ"},{"key":"B19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3322\/caac.21405","article-title":"Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention","volume":"67","author":"Picon-Ruiz","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"B20","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ncb3578","article-title":"Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF","volume":"19","author":"Quail","year":"2017","journal-title":"Nat Cell Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1158\/1078-0432.CCR-15-2239","article-title":"Systemic correlates of white adipose tissue inflammation in early-stage breast cancer","volume":"22","author":"Iyengar","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3892\/mco.2017.1429","article-title":"Triple-negative breast cancer and its association with obesity","volume":"7","author":"Sun","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/jnci\/djt223","article-title":"Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity","volume":"105","author":"Schmitz","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"B24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2217\/imt.15.12","article-title":"Obesity and cancer immunotherapy toxicity","volume":"7","author":"Mirsoian","year":"2015","journal-title":"Immunotherapy"},{"key":"B25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2217\/imt-2018-0133","article-title":"The complicated effects of obesity on cancer and immunotherapy","volume":"11","author":"Wang","year":"2019","journal-title":"Immunotherapy"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1182\/blood-2009-03-213595","article-title":"Obesity accelerates thymic aging","volume":"114","author":"Yang","year":"2009","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.coi.2010.06.010","article-title":"Thymic fatness and approaches to enhance thymopoietic fitness in aging","volume":"22","author":"Dixit","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/eji.201142305","article-title":"Molecular control over thymic involution: from cytokines and microRNA to aging and adipose tissue","volume":"42","author":"Dooley","year":"2012","journal-title":"Eur J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","article-title":"Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade","volume":"25","author":"Wang","year":"2019","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrendo.2017.90","article-title":"Adapting to obesity with adipose tissue inflammation","volume":"13","author":"Reilly","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4049\/jimmunol.1302181","article-title":"Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity","volume":"192","author":"Han","year":"2014","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","article-title":"The association of BMI and outcomes in metastatic melanoma: a retrospective, multicohort analysis of patients treated with targeted therapy, immunotherapy, or chemotherapy","volume":"19","author":"McQuade","year":"2018","journal-title":"Lancet Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.4049\/jimmunol.1701738","article-title":"Cutting edge: elevated leptin during diet-induced obesity reduces the efficacy of tumor immunotherapy","volume":"201","author":"Murphy","year":"2018","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10549-017-4537-5","article-title":"Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study","volume":"167","author":"Dirix","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1158\/1078-0432.CCR-16-2569","article-title":"Immunotherapy for breast cancer: what are we missing?","volume":"23","author":"Vonderheide","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10549-017-4161-4","article-title":"Higher densities of Foxp3(+) regulatory T cells are associated with better prognosis in triple-negative breast cancer","volume":"163","author":"Yeong","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"B37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12967-018-1491-x","article-title":"Gamma-delta (gammadelta) T cells: friend or foe in cancer development?","volume":"16","author":"Zhao","year":"2018","journal-title":"J Transl Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.4049\/jimmunol.1201892","article-title":"Tumor-infiltrating gammadelta T lymphocytes predict clinical outcome in human breast cancer","volume":"189","author":"Ma","year":"2012","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1365-2249.2010.04167.x","article-title":"In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients","volume":"161","author":"Meraviglia","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1158\/2326-6066.CIR-16-0348","article-title":"Squamous cell tumors recruit gammadelta T cells producing either IL17 or IFNgamma depending on the tumor stage","volume":"5","author":"Lo Presti","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.cell.2016.07.046","article-title":"gammadelta T cells support pancreatic oncogenesis by restraining alphabeta T cell activation","volume":"166","author":"Daley","year":"2016","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1189\/jlb.3A0414-211RR","article-title":"gammadelta T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice","volume":"97","author":"Mehta","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0120918","DOI":"10.1371\/journal.pone.0120918","article-title":"Obesity impairs gammadelta T cell homeostasis and antiviral function in humans","volume":"10","author":"Costanzo","year":"2015","journal-title":"PLoS ONE"},{"key":"B45","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fimmu.2017.00643","article-title":"Distinct blood and visceral adipose tissue regulatory T cell and innate lymphocyte profiles characterize obesity and colorectal cancer","volume":"8","author":"Donninelli","year":"2017","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: an update","volume":"196","author":"Michel","year":"2016","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1172\/JCI45816","article-title":"Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity","volume":"121","author":"Mamessier","year":"2011","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/cas.12964","article-title":"A prognostic risk model for patients with triple negative breast cancer based on stromal natural killer cells, tumor-associated macrophages and growth-arrest specific protein 6","volume":"107","author":"Tian","year":"2016","journal-title":"Cancer Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature12998","article-title":"The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells","volume":"507","author":"Paolino","year":"2014","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"32722","DOI":"10.18632\/oncotarget.16281","article-title":"Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer","volume":"8","author":"Park","year":"2017","journal-title":"Oncotarget"},{"key":"B51","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1084\/jem.191.4.661","article-title":"Differential tumor surveillance by natural killer (NK) and NKT cells","volume":"191","author":"Smyth","year":"2000","journal-title":"J Exp Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/oby.2008.565","article-title":"Are natural killer cells protecting the metabolically healthy obese patient?","volume":"17","author":"Lynch","year":"2009","journal-title":"Obesity"},{"key":"B53","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12026-018-8989-4","article-title":"Impaired natural killer cell subset phenotypes in human obesity","volume":"66","author":"Bahr","year":"2018","journal-title":"Immunol Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40608-014-0033-1","article-title":"Altered NK cell function in obese healthy humans","volume":"2","author":"Laue","year":"2015","journal-title":"BMC Obes"},{"key":"B55","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.immuni.2012.06.016","article-title":"Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production","volume":"37","author":"Lynch","year":"2012","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1172\/JCI99317","article-title":"Contribution of NK cells to immunotherapy mediated by PD-1\/PD-L1 blockade","volume":"128","author":"Hsu","year":"2018","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cmet.2017.05.018","article-title":"IL-6\/Stat3-dependent induction of a distinct, obesity-associated NK cell subpopulation deteriorates energy and glucose homeostasis","volume":"26","author":"Theurich","year":"2017","journal-title":"Cell Metab"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/sj.bjc.6601243","article-title":"Altered maturation of peripheral blood dendritic cells in patients with breast cancer","volume":"89","author":"Della Bella","year":"2003","journal-title":"Br J Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1158\/0008-5472.CAN-11-3468","article-title":"Impaired IFN-alpha production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression","volume":"72","author":"Sisirak","year":"2012","journal-title":"Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1158\/1078-0432.CCR-16-1924","article-title":"Dendritic cell vaccination enhances immune responses and induces regression of HER2(pos) DCIS independent of route: results of randomized selection design trial","volume":"23","author":"Lowenfeld","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.4049\/jimmunol.1100587","article-title":"Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth","volume":"189","author":"James","year":"2012","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.2337\/db11-1274","article-title":"Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients","volume":"61","author":"Bertola","year":"2012","journal-title":"Diabetes"},{"key":"B63","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.tranon.2018.03.007","article-title":"Dendritic cell-based immunotherapy for solid tumors","volume":"11","author":"Jung","year":"2018","journal-title":"Transl Oncol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J Cell Physiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12885-018-4284-y","article-title":"Altered monocyte differentiation and macrophage polarization patterns in patients with breast cancer","volume":"18","author":"Hung","year":"2018","journal-title":"BMC Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/bjc.2017.356","article-title":"TAMeless traitors: macrophages in cancer progression and metastasis","volume":"117","author":"Aras","year":"2017","journal-title":"Br J Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10549-010-1154-y","article-title":"Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome","volume":"128","author":"Campbell","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"B68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fonc.2018.00049","article-title":"Targeting macrophages in cancer: from bench to bedside","volume":"8","author":"Poh","year":"2018","journal-title":"Front Oncol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"15919","DOI":"10.1073\/pnas.1312197110","article-title":"Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival","volume":"110","author":"Cieslewicz","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/j.celrep.2016.04.084","article-title":"Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis","volume":"15","author":"Georgoudaki","year":"2016","journal-title":"Cell Rep"},{"key":"B71","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat Rev Clinical Oncol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fcell.2018.00038","article-title":"Targeting tumor-associated macrophages as a potential strategy to enhance the response to immune checkpoint inhibitors","volume":"6","author":"Cassetta","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans","volume":"46","author":"Cinti","year":"2005","journal-title":"J Lipid Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1158\/0008-5472.CAN-13-0926","article-title":"Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis","volume":"73","author":"Arendt","year":"2013","journal-title":"Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1074\/jbc.M109.088708","article-title":"Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype","volume":"285","author":"Ohashi","year":"2010","journal-title":"J Biol Chem"},{"key":"B76","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cellimm.2018.03.001","article-title":"Adipose tissue macrophages and their polarization in health and obesity","volume":"330","author":"Catrysse","year":"2018","journal-title":"Cell Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fimmu.2014.00470","article-title":"Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function?","volume":"5","author":"Kraakman","year":"2014","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fimmu.2018.00398","article-title":"Targeting myeloid-derived suppressor cells to bypass tumor-induced immunosuppression","volume":"9","author":"Fleming","year":"2018","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1182\/blood-2010-11-321752","article-title":"Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL","volume":"117","author":"Sinha","year":"2011","journal-title":"Blood"},{"key":"B81","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00262-017-1977-z","article-title":"Myeloid cells in circulation and tumor microenvironment of breast cancer patients","volume":"66","author":"Toor","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.4049\/jimmunol.1390024","article-title":"Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer","volume":"190","author":"Yu","year":"2013","journal-title":"J Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/JLB.4HI0517-210R","article-title":"Frontline science: high fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells","volume":"103","author":"Clements","year":"2018","journal-title":"J Leukoc Biol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.celrep.2017.10.104","article-title":"CCR5 directs the mobilization of CD11b(+)Gr1(+)Ly6C(low) polymorphonuclear myeloid cells from the bone marrow to the blood to support tumor development","volume":"21","author":"Hawila","year":"2017","journal-title":"Cell Rep"},{"key":"B85","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coi.2018.03.007","article-title":"Myeloid derived-suppressor cells: their role in cancer and obesity","volume":"51","author":"Ostrand-Rosenberg","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1210\/jc.2007-2630","article-title":"CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity","volume":"93","author":"Huber","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B87","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/2159-8290.CD-16-0502","article-title":"Tumor cell-independent estrogen signaling drives disease progression through mobilization of myeloid-derived suppressor cells","volume":"7","author":"Svoronos","year":"2017","journal-title":"Cancer Discov"},{"key":"B88","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/cr.2012.178","article-title":"A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells","volume":"23","author":"Zhang","year":"2013","journal-title":"Cell Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab"},{"key":"B90","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.cell.2017.12.026","article-title":"LXR\/ApoE activation restricts innate immune suppression in cancer","volume":"172","author":"Tavazoie","year":"2018","journal-title":"Cell"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e1344804","DOI":"10.1080\/2162402X.2017.1344804","article-title":"Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells","volume":"6","author":"Al-Khami","year":"2017","journal-title":"Oncoimmunology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1084\/jem.20131219","article-title":"Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy","volume":"210","author":"Bouchlaka","year":"2013","journal-title":"J Exp Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1084\/jem.20140116","article-title":"Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice","volume":"211","author":"Mirsoian","year":"2014","journal-title":"J Exp Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.174.3.561","article-title":"CTLA-4 is a second receptor for the B cell activation antigen B7","volume":"174","author":"Linsley","year":"1991","journal-title":"J Exp Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.bbrc.2013.07.034","article-title":"CTLA-4Ig immunotherapy of obesity-induced insulin resistance by manipulation of macrophage polarization in adipose tissues","volume":"438","author":"Fujii","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B96","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.4049\/jimmunol.1300830","article-title":"CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-beta","volume":"191","author":"Deppong","year":"2013","journal-title":"J Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e15050","DOI":"10.1200\/JCO.2018.36.15_suppl.e15050","article-title":"Effect of immunotherapy of triple negative breast cancer with ROR1 CAR T cells in combination with the TGF-\u00df receptor I kinase inhibitor SD-208","volume":"36","author":"St\u00fcber","year":"2018","journal-title":"J Clin Oncol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13045-016-0285-y","article-title":"Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level","volume":"9","author":"Song","year":"2016","journal-title":"J Hematol Oncol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e1426519","DOI":"10.1080\/2162402X.2018.1426519","article-title":"M7824, a novel bifunctional anti-PD-L1\/TGFbeta Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine","volume":"7","author":"Knudson","year":"2018","journal-title":"Oncoimmunology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01940\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T09:14:08Z","timestamp":1565774048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01940\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,14]]},"references-count":100,"alternative-id":["10.3389\/fimmu.2019.01940"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01940","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,14]]},"article-number":"1940"}}